www.dailypolitical.com Β·
progyny nasdaqpgny versus amn healthcare services nyseamn head to head survey
Topic context
This topic has been covered 318936 times in the last 30 days across our monitored publishers.
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedThis is a financial comparison between two healthcare staffing/service companies. No concrete commercial mechanism (investment, regulation, supply disruption, or price move) is reported. The analysis is purely valuation and profitability comparison without operational business impact. Sector impact is weak; no specific product or supply chain channel identified.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources β not direct quotes from the publisher.
- Progyny (PGNY) revenue $1.29B, net margin 5.23%, ROE 13.34%.
- AMN Healthcare (AMN) revenue $2.73B, net margin -0.95%, EPS -$0.87.
- PGNY consensus price target $28.55 (upside 22.78%), AMN target $25.29 (downside 11.54%).
- PGNY outperformed AMN in 11 of 14 factors analyzed.